About us

At the forefront of biotechnology, we are pioneering two innovations: Rells, reengineered cells that function as programmable living systems, and CBM, continuous biomarker monitoring that expands beyond glucose to track multiple biomarkers in real time. Together, they represent a shift from isolated snapshots to continuous, dynamic insight into health.

Our work bridges synthetic biology, electrochemistry, materials science, rellular engineering, microfluidics, and computational plus biological design. This multidisciplinary approach demands intense, hardcore engineering, but we are committed to pushing the boundaries of what’s possible to advance diagnostics, therapeutics, and personalized health.

Join us as we reimagine biological design and make continuous health monitoring a reality.

Learn more